CLINICAL_TRIALS trial_result · 2022-06-30

Clinical Trial Update: A 16 Week Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Type 2 Diabetes Mellitus [Phase 2]

A Phase 2 clinical trial assessing the efficacy and safety of PF-06882961 in adults with type 2 diabetes has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2022-06-30